111, inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the people's republic of china. it operates through two segments, b2b and b2c. the company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. its product portfolio comprises prescription and over-the counter drugs, such as western and traditional chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. the company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 drug mall, includin
Company profile
Ticker
YI
Exchange
Website
CEO
Jun Ling Liu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
YI stock data
Latest filings (excl ownership)
6-K
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
21 Mar 24
6-K
111 Announces Receipt of Withdrawal of Going Private Proposal
27 Feb 24
6-K
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
30 Nov 23
6-K
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
24 Aug 23
UPLOAD
Letter from SEC
14 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
UPLOAD
Letter from SEC
21 Jul 23
6-K
111, Inc. Announces First Quarter 2023 Unaudited Financial Results
15 Jun 23
20-F
2022 FY
Annual report (foreign)
28 Apr 23
UPLOAD
Letter from SEC
27 Mar 23
Transcripts
YI
Earnings call transcript
2023 Q4
21 Mar 24
YI
Earnings call transcript
2023 Q3
30 Nov 23
YI
Earnings call transcript
2023 Q2
24 Aug 23
YI
Earnings call transcript
2023 Q1
15 Jun 23
YI
Earnings call transcript
2022 Q3
1 Dec 22
YI
Earnings call transcript
2022 Q2
25 Aug 22
YI
Earnings call transcript
2022 Q1
16 Jun 22
YI
Earnings call transcript
2021 Q4
17 Mar 22
YI
Earnings call transcript
2021 Q3
19 Nov 21
YI
Earnings call transcript
2021 Q2
27 Aug 21
Latest ownership filings
SC 13D/A
Gang Yu
27 Feb 24
SC 13D/A
Gang Yu
17 Jul 23
SC 13D/A
Gang Yu
31 Oct 22
SC 13D
Gang Yu
9 Sep 22
SC 13G/A
ClearVue Partners, L.P.
10 Feb 22
SC 13G/A
Verlinvest Asia (HK) Ltd
27 May 21
SC 13G/A
ClearVue Partners, L.P.
5 Feb 21
SC 13G/A
111, Inc.
24 Feb 20
SC 13G/A
111, Inc.
29 Jan 20
SC 13G
111, Inc.
14 Feb 19
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 1 |
Closed positions | 4 |
Increased positions | 6 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 3.70 bn |
Total shares | 63.79 mm |
Total puts | 100.00 |
Total calls | 100.00 |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Gang Yu | 36.00 mm | $0.00 |
ClearVue Partners | 18.35 mm | $64.22 mm |
Verlinvest Asia | 7.62 mm | $136.00 mm |
JPM JPMorgan Chase & Co. | 724.92 k | $1.78 bn |
Greenwoods Asset Management Hong Kong | 348.86 k | $858.06 mm |
BCS Barclays | 329.80 k | $811.00 k |
Renaissance Technologies | 151.35 k | $372.00 k |
STT State Street | 93.23 k | $229.35 mm |
Prelude Capital Management | 48.50 k | $119.29 mm |
Geode Capital Management | 33.10 k | $81.43 mm |